Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India.
Department of Radio Diagnosis and Imaging, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India.
Dig Dis Sci. 2022 Aug;67(8):4146-4153. doi: 10.1007/s10620-021-07201-0. Epub 2021 Aug 17.
Percutaneous catheter drainage (PCD's) are prone to blockage because of necrosum. To improve the efficacy of PCD, necrolytic agents have been used. The present study compared the use of Streptokinase with HO in saline irrigation.
This is a single-center randomized pilot study (from July 2018 to Dec 2019). Patients with infected pancreatic necrosis not showing response to PCD and saline irrigation were included in the study. Patients received either Streptokinase (Streptokinase group 50,000 IU in 100 ml normal saline) or 3% HO (3% HO in 100 ml normal saline in 1:10 dilution). Primary endpoints were the need for surgery and mortality while secondary endpoints were hospital stay and complications attributable to necrolytic agents.
There were 30 patients in the study, 15 in each arm. Organ failure was seen in 23 (76.6%), single organ failure was present in 11 (47%), and multi-organ failure in 12 (53%). Bleeding complications (20% in HO vs 6.6% in Streptokinase), need for surgery (73% in HO vs 33.3% in Streptokinase) and mortality (60% in HO vs 33% in Streptokinase) were higher in HO group but the difference was not significant statistically. Post-irrigation hospital stay was lesser in the Streptokinase group compared to HO group but the difference did not reach statistical significance (14.1 ± 7.7 vs 19.2 ± 11.7, p = 0.09) CONCLUSIONS: Streptokinase irrigation led to a trend for reduced need for necrosectomy and mortality. HO group had more bleeding complications Post-irrigation hospital stay was lesser in Streptokinase group.
经皮导管引流(PCD)由于坏死而容易堵塞。为了提高 PCD 的疗效,已经使用了坏死剂。本研究比较了链激酶与双氧水在生理盐水冲洗中的应用。
这是一项单中心随机试点研究(2018 年 7 月至 2019 年 12 月)。纳入研究的患者为对 PCD 和生理盐水冲洗无反应的感染性胰腺坏死。患者接受链激酶(链激酶组 50,000IU 加入 100ml 生理盐水)或 3%双氧水(3%双氧水在 100ml 生理盐水 1:10 稀释)。主要终点是需要手术和死亡率,次要终点是与坏死剂相关的住院时间和并发症。
研究中有 30 名患者,每组 15 名。23 名(76.6%)患者出现器官衰竭,11 名(47%)患者出现单一器官衰竭,12 名(53%)患者出现多器官衰竭。出血并发症(HO 组 20%,链激酶组 6.6%)、需要手术(HO 组 73%,链激酶组 33.3%)和死亡率(HO 组 60%,链激酶组 33%)在 HO 组较高,但统计学上无显著差异。与 HO 组相比,链激酶组术后住院时间较短,但差异无统计学意义(14.1±7.7 与 19.2±11.7,p=0.09)。
链激酶冲洗导致需要坏死切除术和死亡率降低的趋势。HO 组术后出血并发症较多。链激酶组术后住院时间较短。